Choosing drugs for the treatment of diabetic neuropathy

Bibliography

• CDC - 2011 National Diabetes Fact Sheet - Publications - Diabetes DDT [Internet]. cdc.gov. Available from: http://www.cdc.gov/diabetes/pubs/factsheet11.htm [Last accessed 28 August 2013]
   Google Scholar
• Pirart J. Diabetes mellitus and its degenerative complications; A prospective study of 4,400 patients observed between 1947 and 1973D. Diabetes Care 1978;1:168-88.252-63
   Google Scholar
• Callaghan BC, Cheng HT, Stables CL, et al. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurology 2012;11:521-34
   PubMed Web of Science ®Google Scholar
• Ziegler D, Papanas N, Vinik AI, Shaw JE. Epidemiology of polyneuropathy in diabetes and prediabetes. Handb Clin Neurol 2014;126:3-22
   PubMedGoogle Scholar
• Watkins P. The UKPDS. A model for gathering the evidence for the management of chronic diseases. JR Coll Physicians Lond 1998;32:510-11
   Google Scholar
• Dyck PJ, Benstead TJ, Conn DL, et al. Nonsystemic vasculitic neuropathy. Brain 1987;110(Pt 4):843-53
   PubMed Web of Science ®Google Scholar
• Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 2002;25:565-9
   PubMed Web of Science ®Google Scholar
• Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-7
   PubMed Web of Science ®Google Scholar
• Ollendorf DA, Kotsanos JG, Wishner WJ, et al. Potential economic benefits of lower-extremity amputation prevention strategies in diabetes. Diabetes Care 1998;21:1240-5
   PubMed Web of Science ®Google Scholar
• Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29:1518-22
   PubMed Web of Science ®Google Scholar
• Vukojevic Z, Pekmezovic T, Nikolic A, et al. Correlation of clinical and neurophysiological findings with health-related quality of life in patients with diabetic polyneuropathy. Vojnosanit Pregl 2014;71:833-8
   PubMed Web of Science ®Google Scholar
• Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-8
   PubMed Web of Science ®Google Scholar
• Selvarajah D, Cash T, Sankar A, et al. The contributors of emotional distress in painful diabetic neuropathy. Diab Vasc Dis Res 2014;11:218-25
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial Group. Effect of Intensive Diabetes Treatment on Nerve Conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995;38:869-80
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-353
   PubMed Web of Science ®Google Scholar
• Callaghan BC, Little AA, Feldman EL, Hughes RAC. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 2012;6:CD007543
   PubMed Web of Science ®Google Scholar
• Bril V, England J, Franklin GM, et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011;76:1758-65
   PubMed Web of Science ®Google Scholar
• Gordois A, Scuffham P, Shearer A, et al. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003;26:1790-5
   PubMed Web of Science ®Google Scholar
• Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956-62
   PubMed Web of Science ®Google Scholar
• Bril V. Treatments for diabetic neuropathy. J Peripher Nerv Syst 2012;17(Suppl 2):22-7
   PubMed Web of Science ®Google Scholar
• Chong MS, Hester J. Diabetic painful neuropathy: current and future treatment options. Drugs 2007;67:569-685
   PubMed Web of Science ®Google Scholar
• Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004;21:976-82
   PubMed Web of Science ®Google Scholar
• Cruccu G, Sommer C, Anand P, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 2010;17:1010-18
   PubMed Web of Science ®Google Scholar
• Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the neuropathic pain symptom inventory. Pain 2004;108:248-57
   PubMed Web of Science ®Google Scholar
• Spallone V, Morganti R, D’Amato C, et al. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med 2012;29:578-85
   PubMed Web of Science ®Google Scholar
• Farrar JT, Young JPJr, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58
   PubMed Web of Science ®Google Scholar
• Farrar JT, Pritchett YL, Robinson M, et al. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders. J Pain 2010;11:109-18
   PubMed Web of Science ®Google Scholar
• Farrar JT, Polomano RC, Berlin JA, Strom BL. A comparison of change in the 0-10 numeric rating scale to a pain relief scale and global medication performance scale in a short-term clinical trial of breakthrough pain intensity. Anesthesiology 2010;112:1464-72
   PubMed Web of Science ®Google Scholar
• Bouhassira D, Attal N. Diagnosis and assessment of neuropathic pain: the saga of clinical tools. Pain 2011;152:S74-583
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Vileikyte L, Rayman G, et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev 2011;27:629-38
   PubMed Web of Science ®Google Scholar
• Management of painful diabetic neuropathy: guideline guidance or jungle? 2012.12:403-13. Available from: http://link.springer.com/10.1007/s11892-012-0287-2
   Google Scholar
• Albers JW, Feldman EL. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care 2010;33:1090-6
   PubMed Web of Science ®Google Scholar
• Reichard P, Berglund B, Britz A, et al. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 1991;230:101-8
   PubMed Web of Science ®Google Scholar
• Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-9
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Miller ME, Genuth S, et al. ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011;364:818-28
   PubMed Web of Science ®Google Scholar
• Boulton AJM, Kempler P, Ametov A, Ziegler D. Whither pathogenetic treatments for diabetic polyneuropathy? Diabetes Metab Res Rev 2013;29:327-33
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341-50
   PubMed Web of Science ®Google Scholar
• Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006;29:1294-9
   PubMed Web of Science ®Google Scholar
• Hung J, Liou C, Wang P, et al. Effect of 12-week Tai Chi Chuan exercise on peripheral nerve modulation in patients with type 2 diabetes mellitus. J Rehabil Med 2009;41:924-9
   PubMed Web of Science ®Google Scholar
• Malik RA, Williamson S, Abbott C, et al. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1998;352:1978-81
   PubMed Web of Science ®Google Scholar
• Zangiabadi N, Shafiee K, Alavi KH, et al. Atorvastatin treatment improves diabetic polyneuropathy electrophysiological changes in non-insulin dependent diabetic patients: a double blind, randomized clinical trial. Minerva Endocrinol 2012;37:195-200
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Norell JE, Tritschler H, et al. Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care 2007;30:2619-25
   PubMed Web of Science ®Google Scholar
• Chalk C, Benstead TJ, Moore F. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Database Syst Rev 2007;CD004572
   Google Scholar
• Apfel SC. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int Rev Neurobiol 2002;50:393-413
   PubMed Web of Science ®Google Scholar
• Bansal D, Badhan Y, Gudala K, Schifano F. Ruboxistaurin for the treatment of diabetic peripheral neuropathy: a systematic review of randomized clinical trials. Diabetes Metab J 2013;37:375-84
   PubMedGoogle Scholar
• Ziegler D, Low PA, Litchy WJ, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 2011;34:2054-60
   PubMed Web of Science ®Google Scholar
• Bril V, Perkins B, Toth C; Canadian Diabetes Association CDA Clinical Practice Guidelines. Neuropathy. Can J Diabetes 2013;37(Suppl 1):S142-4
   PubMed Web of Science ®Google Scholar
• Razazian N, Baziyar M, Moradian N, et al. Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial. Neurosciences (Riyadh) 2014;19:192-8
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Peirce-Sandner S, et al. Placebo and treatment group responses in postherpetic neuralgia vs. painful diabetic peripheral neuropathy clinical trials in the REPORT database. Pain 2010;150:12-16
   PubMed Web of Science ®Google Scholar
• Arakawa A, Kaneko M, Narukawa M. An investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysis. Clin Drug Investig 2015;35:67-81
   PubMed Web of Science ®Google Scholar
• Dogra S, Beydoun S, Mazzola J, et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 2005;9:543-54
   PubMed Web of Science ®Google Scholar
• Vinik AI, Tuchman M, Safirstein B, et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain 2007;128:169-79
   PubMed Web of Science ®Google Scholar
• Smith J, Whitehall J. Sodium valproate and the fetus: a case study and review of the literature. Neonatal Netw 2009;28:363-7
   PubMedGoogle Scholar
• Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004;110:697-706
   PubMed Web of Science ®Google Scholar
• Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 2001;3:53-62
   PubMedGoogle Scholar
• Wang F, Waninger AL, Iyengar S. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005;6:346-56
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-18
   PubMed Web of Science ®Google Scholar
• Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589-96
   PubMed Web of Science ®Google Scholar
• Vrethem M, Boivie J, Arnqvist H, et al. A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 1997;13:313-23
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Farrar JT, Backonja MM, et al. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain 2007;23:287-99
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:1113-88
   PubMed Web of Science ®Google Scholar
• Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration (US). 2004. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=22514846&retmode=ref&cmd=prlinks
   Google Scholar
• Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2004. CD003726 Available from: http://doi.wiley.com/10.1002/14651858.CD003726.pub2
   Google Scholar
• Bril V. Therapeutic Insights - Managing Painful Diabetic Neuropathy. 2015. Available from: http://scme.ama-assn.orgActivityDetail.aspx
   Google Scholar
• Sang CN, Booher S, Parada S. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 2002;96:1053-61
   PubMed Web of Science ®Google Scholar
• Nelson KA, Park KM, Robinovitz E, Tsigos C. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997;48:1212-18
   PubMed Web of Science ®Google Scholar
• Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324-34
   PubMed Web of Science ®Google Scholar
• Haraati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;1950:1842-6
   Google Scholar
• Sindrup SH, Andersen G, Madsen C, et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 1999;83:85-90
   PubMed Web of Science ®Google Scholar
• Shenoy AM. Guidelines in practice: treatment of painful diabetic neuropathy. Continuum (Minneap Minn) 2012.18:192-8 Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00132979-201202000-00018
   Google Scholar
• Wang H, Romano G, Frustaci ME, et al. Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial. Neurology 2014;83:628-37
   PubMed Web of Science ®Google Scholar
• Rajanandh MG, Kosey S, Prathiksha G. Assessment of antioxidant supplementation on the neuropathic pain score and quality of life in diabetic neuropathy patients - a randomized controlled study. Pharmacol Rep 2014;66:44-8
   PubMed Web of Science ®Google Scholar
• Moore RA, Wiffen PJ, Derry S, Lunn MP. Zonisamide for neuropathic pain in adults. Cochrane Database Syst Rev 2015;1:CD011241
   PubMedGoogle Scholar
• Agrawal RP, Jain S, Goyal S, et al. A clinical trial of nitrosense patch for the treatment of patients with painful diabetic neuropathy. J Assoc Physicians India 2014;62:385-90
   PubMedGoogle Scholar
• Schwartz S, Etropolski MS, Shapiro DY, et al. A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy. Clin Drug Investig 2015;35:95-108
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang X, Zhang B. Efficacy and safety of puerarin injection in treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials. J Tradit Chin Med 2014;34:401-10
   PubMed Web of Science ®Google Scholar
• Oyibo SO, Breislin K, Boulton AJ. Electrical stimulation therapy through stocking electrodes for painful diabetic neuropathy: a double blind, controlled crossover study. Diabet Med 2004;21:940-4
   PubMed Web of Science ®Google Scholar
• Weintraub MI, Cole SP. Pulsed magnetic field therapy in refractory neuropathic pain secondary to peripheral neuropathy: electrodiagnostic parameters–pilot study. Neurorehabil Neural Repair 2004.18(1):42-6 Available from: http://nnr.sagepub.com/cgi/doi/10.1177/0888439003261024
   Google Scholar
• Zinman LH, Ngo M, Ng ET, et al. Low-intensity laser therapy for painful symptoms of diabetic sensorimotor polyneuropathy: a controlled trial. Diabetes Care 2004;27:921-4
   PubMed Web of Science ®Google Scholar
• Kästenbauer T, Irsigler P, Sauseng S, et al. The prevalence of symptoms of sensorimotor and autonomic neuropathy in Type 1 and Type 2 diabetic subjects. J Diabetes Complications 2004;18:27-31
   PubMed Web of Science ®Google Scholar
• Katzberg H, Kokokyi S, Halpern E, et al. Prevalence of muscle cramps in patients with diabetes. Diabetes Care 2014;37:e17-18
   PubMed Web of Science ®Google Scholar
• Maxwell SK, Barnett C, Kokokyi S, et al. Association of social support with quality of life in patients with polyneuropathy. J Peripher Nerv Syst 2013;18:37-43
   PubMed Web of Science ®Google Scholar
• Katzberg HD, Khan AH, So YT. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 2010;74:691-6
   PubMed Web of Science ®Google Scholar
• Fat MJL, Kokokyi S, Katzberg HD. Neurologist practice patterns in treatment of muscle cramps in Canada. J Foot Ankle Res 2013;6:2
   PubMed Web of Science ®Google Scholar
• Laughlin RS, Dyck PJB. Diabetic radiculoplexus neuropathies. Handb Clin Neurol 2014;126:45-52
   PubMedGoogle Scholar
• Massie R, Mauermann ML, Staff NP, et al. Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. Brain 2012;135:3074-88
   PubMed Web of Science ®Google Scholar
• Younger DS. Diabetic lumbosacral radiculoplexus neuropathy: a postmortem studied patient and review of the literature. J Neurol 2011;258:1364-7
   PubMed Web of Science ®Google Scholar
• Garces-Sanchez M, Laughlin RS, Dyck PJ, et al. Painless diabetic motor neuropathy: a variant of diabetic lumbosacral radiculoplexus Neuropathy? Ann Neurol 2011;69:1043-54
   PubMed Web of Science ®Google Scholar
• Zochodne DW, Isaac D, Jones C. Failure of immunotherapy to prevent, arrest or reverse diabetic lumbosacral plexopathy. Acta Neurol Scand 2003;107:299-301
   PubMed Web of Science ®Google Scholar
• Dunnigan SK, Ebadi H, Breiner A, et al. Conduction slowing in diabetic sensorimotor polyneuropathy. Diabetes Care 2013;36:3684-90
   PubMed Web of Science ®Google Scholar
• Dunnigan SK, Ebadi H, Breiner A, et al. Comparison of diabetes patients with “demyelinating” diabetic sensorimotor polyneruopathy to those diagnosed with CIDP. Brain & Behavior 2013;656-63
   PubMed Web of Science ®Google Scholar
• Dunnigan SK, Ebadi H, Breiner A, et al. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes–an observational study. PLoS One 2014;9:e89344
   PubMed Web of Science ®Google Scholar
• Rotta FT, Sussman AT, Bradley WG, et al. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2000;173:129-39
   PubMed Web of Science ®Google Scholar
• Abraham A, Breiner A, Katzberg HD, et al. Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP. Expert Rev Clin Immunol 2015;11:1-10
   PubMed Web of Science ®Google Scholar
• Papanas N, Ziegler D. Efficacy of alpha-lipoic acid in diabetic neuropathy. Expert Opin Pharmacother 2014;15:2721-31
   PubMed Web of Science ®Google Scholar